Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Banco Macro (BMA) — Positive

BMA   Zacks Investment Research — June 10, 2025

The heavy selling pressure might have exhausted for Banco Macro (BMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

image for news Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Banco Macro (BMA)

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=152439&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

image for news July 14, 2025 Deadline: Join Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152437&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

image for news July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=152436&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

image for news Class Action Lawsuit Filed Against Krispy Kreme, Inc. (DNUT) - Recover Losses - Contact Levi & Korsinsky Before July 15, 2025

Downgrade Pressures McDonald's Stock Lower — Negative

MCD   Schaeffers Research — June 10, 2025

Redburn Atlantic earlier downgraded the shares of blue-chip fast food giant McDonald's Corp (NYSE:MCD) to "sell" form "buy," and cut its price target to $260 from $319.

image for news Downgrade Pressures McDonald's Stock Lower

NEW YORK, June 10, 2025 /PRNewswire/ -- Tiger Capital Group's lending platform, Tiger Finance, has provided $35 million in financing to The Beachbody Company, Inc. (NYSE:BODI), a leading fitness and nutrition company.

image for news Tiger Finance Provides $35 Million in Funding for The Beachbody Co.

Arista 2.0 Strategy Gaining Traction: Is it the Next Key Growth Driver? — Positive

ANET   Zacks Investment Research — June 10, 2025

ANET's Arista 2.0 strategy gains momentum with AI, SaaS and new markets driving its next wave of growth.

image for news Arista 2.0 Strategy Gaining Traction: Is it the Next Key Growth Driver?

Sezzle Stock Skyrockets 1000% in a Year: Should You Buy It Now? — Positive

SEZL   Zacks Investment Research — June 10, 2025

SEZL is outpacing BNPL rivals with surging revenues, leaner operations and rising analyst confidence in 2025.

image for news Sezzle Stock Skyrockets 1000% in a Year: Should You Buy It Now?

Lakeland's Q1 Earnings Miss Estimates, Sales Increase Y/Y — Negative

LAKE   Zacks Investment Research — June 10, 2025

LAKE posts Q1 loss despite 28.7% sales growth, hit by rising costs and shrinking gross margins.

image for news Lakeland's Q1 Earnings Miss Estimates, Sales Increase Y/Y

Silver ETF (SIVR) Hits New 52-Week High — Negative

SIVR   Zacks Investment Research — June 10, 2025

SIVR hits a 52-week high as silver surges past $36 amid supply deficits, dollar weakness and geopolitical uncertainty.

image for news Silver ETF (SIVR) Hits New 52-Week High

Brokers Suggest Investing in Enterprise Products (EPD): Read This Before Placing a Bet — Neutral

EPD   Zacks Investment Research — June 10, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Brokers Suggest Investing in Enterprise Products (EPD): Read This Before Placing a Bet

Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views? — Positive

ISRG   Zacks Investment Research — June 10, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views?

PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The 7 major bladder cancer markets are expected to reach $5.4 billion by 2034. Company is developing anti-CTLA4 antibody UGN-301 in a phase 1 study either alone as a monotherapy or in combination to target patients with recurrent high-grade non-muscle invasive bladder cancer.

image for news UroGen: Despite ODAC Vote, Hope Remains With Targeting Of Other  Cancer Subpopulation

Is CleanSpark (CLSK) a Buy as Wall Street Analysts Look Optimistic? — Positive

CLSK   Zacks Investment Research — June 10, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Is CleanSpark (CLSK) a Buy as Wall Street Analysts Look Optimistic?

Wall Street Analysts See Dell Technologies (DELL) as a Buy: Should You Invest? — Negative

DELL   Zacks Investment Research — June 10, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Wall Street Analysts See Dell Technologies (DELL) as a Buy: Should You Invest?

Brokers Suggest Investing in Affirm Holdings (AFRM): Read This Before Placing a Bet — Negative

AFRM   Zacks Investment Research — June 10, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Brokers Suggest Investing in Affirm Holdings (AFRM): Read This Before Placing a Bet

Wall Street Analysts Look Bullish on Axon (AXON): Should You Buy? — Positive

AXON   Zacks Investment Research — June 10, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Analysts Look Bullish on Axon (AXON): Should You Buy?

Should You Invest in TSMC (TSM) Based on Bullish Wall Street Views? — Positive

TSM   Zacks Investment Research — June 10, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Should You Invest in TSMC (TSM) Based on Bullish Wall Street Views?

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.

image for news Investigation Underway: Tempus AI, Inc. (TEM) - Contact Levi & Korsinsky Over Securities Law Violations

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news TMCI DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action - TMCI